VHCP Management as of Dec. 31, 2011
Portfolio Holdings for VHCP Management
VHCP Management holds 14 positions in its portfolio as reported in the December 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medivation | 17.4 | $30M | 650k | 46.11 | |
| Ironwood Pharmaceuticals (IRWD) | 16.7 | $29M | 2.4M | 11.97 | |
| Neurocrine Biosciences (NBIX) | 14.5 | $25M | 2.9M | 8.50 | |
| Chelsea Therapeutics International | 11.6 | $20M | 3.9M | 5.13 | |
| NPS Pharmaceuticals | 7.4 | $13M | 1.9M | 6.59 | |
| Anacor Pharmaceuticals In | 7.2 | $12M | 2.0M | 6.20 | |
| Ardea Biosciences | 5.3 | $9.2M | 545k | 16.81 | |
| DepoMed | 4.4 | $7.6M | 1.5M | 5.18 | |
| GTx | 4.2 | $7.1M | 2.1M | 3.36 | |
| Zogenix | 3.2 | $5.6M | 2.5M | 2.22 | |
| DURECT Corporation | 3.0 | $5.2M | 4.4M | 1.18 | |
| Anthera Pharmaceuticals | 2.4 | $4.1M | 675k | 6.14 | |
| ACADIA Pharmaceuticals (ACAD) | 2.1 | $3.6M | 3.4M | 1.08 | |
| Ym Biosciences | 0.4 | $663k | 404k | 1.64 |
